Browse All

Current Filters

CLEAR FILTER x

TITLE

Diagnostic Guidelines for Identifying and Monitoring Cognitive Impairment in Multiple Sclerosis: An IMSCOGS and ECTRIMS Delphi Consensus Statement

Author:Morrow, Sarah   Hancock, Laura   Nonino, Francesco   Desantis, Claudia   Schettino, Martino   Langdon, Dawn   Amato, Maria Pia   Schoonheim, Menno   

Session Name:P1: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 1  

Topic:Multiple Sclerosis  

Program Number:P1.011  

Author Institution:University of Calgary, Hotchkiss Brain Institute, calgary, AB, Canada  Cleveland Clinic, Cleveland, OH  Cochrane Review Group Multiple Sclerosis and Rare Diseases of the CNS, Italy  Royal Holloway, Egham, United Kingdom  University of Florence, Italy  Amsterdam University Medical Center, Amsterdam, Netherlands  

Seizure Characteristics Differ Among Grade Four Glioma Subtypes

Author:Guo, Lydia   Rilinger, Ryan   Sharma, Akshay   Volovetz, Josephine   Lobbous, Mina   Grabowski, Matthew   

Session Name:P3: Neuro-oncology: Supportive Care and Health Care Delivery 2  

Topic:Neuro-oncology  

Program Number:P3.004  

Author Institution:Cleveland Clinic, Cleveland, OH  

Quantitative Differences in REM Sleep Without Atonia Among Narcolepsy Type One, Narcolepsy Type Two, and Idiopathic Hypersomnia

Author:Thanaviratananich, Sikawat   Ryan, Delaney   Bena, James   El Ahdab, Jad   Foldvary-Schaefer, Nancy   

Session Name:P3: Sleep: Pathophysiology  

Topic:Sleep  

Program Number:P3.010  

Author Institution:Cleveland Clinic Foundation, OH  Cleveland Clinic Foundation, Cleveland, OH  Cleveland Clinic, Cleveland, OH  

Feasibility of Digital Health and Wearable Technology Interventions for Secondary Stroke Prevention

Author:Badihian, Shervin   Ong, Bradley   Fedorova, Margarita   Nero, Neil   Uchino, Ken   Man, Shumei   

Session Name:P3: Cerebrovascular Disease and Interventional Neurology: Risk and Prevention  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P3.012  

Author Institution:Cleveland Clinic, Cleveland, OH  Cleveland Clinic Main Campus - Neurological Institute, Cleveland, OH  Cleveland Clinic Foundation, Cleveland, OH  

Real-world Tolerability, Safety, and Effectiveness of Ofatumumab in Adults With Multiple Sclerosis Over 36 Months

Author:Arias, Diana   Musser, Leah   Carrabe, Kailey   Du, Mengke   Conway, Devon   Amin, Moein   Hersh, Carrie   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.002  

Author Institution:Cleveland Clinic Foundation, Aurora, OH  Cleveland Clinic Foundation, Westlake, OH  Touro University, NV  Cleveland Clinic, Cleveland, OH  Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV